Company news
ProtoKinetix, Inc. news in 2019
ProtoKinetix, Inc.'s news releases, calls and decks from 2019, newest first.
ProtoKinetix AAGP® Retinal Cell Replacement Therapy Testing at UBC Completed
December 19, 2019
ProtoKinetix AAGP® Dry Eye Therapy Program Launched
November 22, 2019
ProtoKinetix AAGP® Operational Update
November 6, 2019
Tests Show AAGP® Preserved and Enabled Retinal Cells to Mature Without Compromise after 5-Month Milestone
August 23, 2019
ProtoKinetix Reaches Mid-Point of 3rd Stage of Retinal Cell Replacement Therapy Testing at UBC
July 9, 2019
ProtoKinetix Achieves Primary Objective Safety at Midpoint of Clinical Trial
June 7, 2019
ProtoKinetix First in Series of Town Hall Shareholder Meetings
May 30, 2019
Agreement Secured by ProtoKinetix to Start Heart Research Product Validation Studies
May 9, 2019
ProtoKinetix Discusses Investor Awareness Campaign and Recent Market Activity
May 6, 2019
ProtoKinetix AAGP® in Phase 3 Retinal Replacement Program
April 23, 2019
ProtoKinetix Releases Third in a Series of Scientific Update Videos
February 26, 2019
ProtoKinetix Releases Second in a Series of Scientific Update Videos
January 16, 2019
Decks in 2019
- Investor Presentation (June 2019)
Investor deck · 20 slides · June 2019